104 related articles for article (PubMed ID: 30014237)
1. Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes.
Sabatino R; Battistelli S; Magnani M; Rossi L
Drug Deliv Transl Res; 2018 Oct; 8(5):1355-1364. PubMed ID: 30014237
[TBL] [Abstract][Full Text] [Related]
2. Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells.
Sabatino R; Antonelli A; Battistelli S; Schwendener R; Magnani M; Rossi L
PLoS One; 2014; 9(6):e101260. PubMed ID: 24968029
[TBL] [Abstract][Full Text] [Related]
3. Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours.
Petruk N; Sousa S; Croset M; Polari L; Zlatev H; Selander K; Mönkkönen J; Clézardin P; Määttä J
Eur J Pharm Sci; 2023 Nov; 190():106571. PubMed ID: 37652236
[TBL] [Abstract][Full Text] [Related]
4. Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy.
Zang X; Zhang X; Hu H; Qiao M; Zhao X; Deng Y; Chen D
Mol Pharm; 2019 May; 16(5):2249-2258. PubMed ID: 30969779
[TBL] [Abstract][Full Text] [Related]
5. Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells.
Sousa S; Auriola S; Mönkkönen J; Määttä J
BMC Cancer; 2015 Jan; 15():4. PubMed ID: 25588705
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype.
Xu M; Liu M; Du X; Li S; Li H; Li X; Li Y; Wang Y; Qin Z; Fu YX; Wang S
J Immunol; 2015 May; 194(10):4997-5006. PubMed ID: 25876763
[TBL] [Abstract][Full Text] [Related]
7. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
Zhou S; Zhang T; Peng B; Luo X; Liu X; Hu L; Liu Y; Di D; Song Y; Deng Y
Int J Pharm; 2017 May; 523(1):203-216. PubMed ID: 28336455
[TBL] [Abstract][Full Text] [Related]
9. Effect of Liposome-Encapsulated Zoledronic Acid on Microenvironment of Hepatocellular Carcinoma May Depend on the Ratio Between M1 and M2 Polarized Macrophages.
Wu S; Lin X; Cui X
Bull Exp Biol Med; 2020 Nov; 170(1):69-74. PubMed ID: 33237530
[TBL] [Abstract][Full Text] [Related]
10. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
Sun X; Gao D; Gao L; Zhang C; Yu X; Jia B; Wang F; Liu Z
Theranostics; 2015; 5(6):597-608. PubMed ID: 25825599
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K; Bansal R; Storm G; Prakash J
FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
[TBL] [Abstract][Full Text] [Related]
13. Calcium Bisphosphonate Nanoparticles with Chelator-Free Radiolabeling to Deplete Tumor-Associated Macrophages for Enhanced Cancer Radioisotope Therapy.
Tian L; Yi X; Dong Z; Xu J; Liang C; Chao Y; Wang Y; Yang K; Liu Z
ACS Nano; 2018 Nov; 12(11):11541-11551. PubMed ID: 30359515
[TBL] [Abstract][Full Text] [Related]
14. Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer.
Dang W; Tang H; Cao H; Wang L; Zhang X; Tian W; Pang X; Li K; Chen T
Gene Ther; 2015 Dec; 22(12):977-83. PubMed ID: 26181625
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
16. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
17. Dual-targeting tumor cells and tumor associated macrophages with lipid coated calcium zoledronate for enhanced lung cancer chemoimmunotherapy.
Zang X; Zhou J; Zhang X; Chen D; Han Y; Chen X
Int J Pharm; 2021 Feb; 594():120174. PubMed ID: 33338567
[TBL] [Abstract][Full Text] [Related]
18. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.
Zhan X; Jia L; Niu Y; Qi H; Chen X; Zhang Q; Zhang J; Wang Y; Dong L; Wang C
Biomaterials; 2014 Dec; 35(38):10046-57. PubMed ID: 25245263
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration.
Song H; Jung JI; Cho HJ; Her S; Kwon SH; Yu R; Kang YH; Lee KW; Park JH
J Nutr Biochem; 2015 Nov; 26(11):1368-78. PubMed ID: 26297476
[TBL] [Abstract][Full Text] [Related]
20. The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis.
Luo KW; Yue GG; Ko CH; Gao S; Lee JK; Li G; Fung KP; Leung PC; Lau CB
Oncol Rep; 2015 Jul; 34(1):477-87. PubMed ID: 25998578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
